ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
747 hedge funds and large institutions have $31.2B invested in Alexion Pharmaceuticals in 2021 Q1 according to their latest regulatory filings, with 83 funds opening new positions, 242 increasing their positions, 311 reducing their positions, and 148 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
24% less call options, than puts
Call options by funds: $202M | Put options by funds: $267M
44% less first-time investments, than exits
New positions opened: 83 | Existing positions closed: 148
Holders
747
Holding in Top 10
70
Calls
$202M
Puts
$267M
Top Buyers
| 1 | +$612M | |
| 2 | +$539M | |
| 3 | +$526M | |
| 4 |
Barclays
London,
United Kingdom
|
+$491M |
| 5 |
Citigroup
New York
|
+$330M |
Top Sellers
| 1 | -$917M | |
| 2 | -$729M | |
| 3 | -$421M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$314M |
| 5 |
JPMorgan Chase & Co
New York
|
-$313M |